Improving walking speed reduces hospitalization costs in outpatients with cardiovascular disease. An analysis based on a multistrata non-parametric test.

Cardiovascular disease Hospitalization costs Permutation test Physical activity Secondary prevention

Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
17 Nov 2020
Historique:
received: 25 05 2020
accepted: 28 10 2020
entrez: 18 11 2020
pubmed: 19 11 2020
medline: 15 5 2021
Statut: epublish

Résumé

To assess the association between walking speed (WS) and its improvement on hospitalization rates and costs in outpatients with cardiovascular disease. Six hundred forty-nine patients participating in an exercise-based secondary prevention program were studied. Patients were divided at baseline into two groups characterized by low and high WS based on the average WS maintained during a moderate 1-km treadmill-walking test. WS and other covariates were grouped into three domains (demographic factors, medical history and risk factors), and used to estimate a propensity score, in order to create homogeneous groups of patients. All-cause hospitalization was assessed 3 years after baseline as a function of WS. Hospitalization and related costs were also assessed during the fourth-to-sixth years after enrollment. To test whether the hospitalization costs were related to changes in WS after 36 months, a multistrata permutation test was performed by combining within strata partial tests. The results support the hypothesis that hospitalization costs are significantly reduced in accordance with an improvement in WS. This effect is most evident among older patients, overweight or obese, smokers, and those without a history of coronary artery bypass surgery. The present study supports growing evidence of an inverse association between WS, risk of hospitalization and consequent health-care costs. The joint use of propensity score and multistrata permutation approaches represent a flexible and robust testing method which avoids the possible effects of several confounding factors typical of these studies.

Sections du résumé

BACKGROUND BACKGROUND
To assess the association between walking speed (WS) and its improvement on hospitalization rates and costs in outpatients with cardiovascular disease.
METHODS METHODS
Six hundred forty-nine patients participating in an exercise-based secondary prevention program were studied. Patients were divided at baseline into two groups characterized by low and high WS based on the average WS maintained during a moderate 1-km treadmill-walking test. WS and other covariates were grouped into three domains (demographic factors, medical history and risk factors), and used to estimate a propensity score, in order to create homogeneous groups of patients. All-cause hospitalization was assessed 3 years after baseline as a function of WS. Hospitalization and related costs were also assessed during the fourth-to-sixth years after enrollment. To test whether the hospitalization costs were related to changes in WS after 36 months, a multistrata permutation test was performed by combining within strata partial tests.
RESULTS RESULTS
The results support the hypothesis that hospitalization costs are significantly reduced in accordance with an improvement in WS. This effect is most evident among older patients, overweight or obese, smokers, and those without a history of coronary artery bypass surgery.
CONCLUSIONS CONCLUSIONS
The present study supports growing evidence of an inverse association between WS, risk of hospitalization and consequent health-care costs. The joint use of propensity score and multistrata permutation approaches represent a flexible and robust testing method which avoids the possible effects of several confounding factors typical of these studies.

Identifiants

pubmed: 33203408
doi: 10.1186/s12913-020-05874-3
pii: 10.1186/s12913-020-05874-3
pmc: PMC7670683
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1048

Subventions

Organisme : RRD VA
ID : IK6 RX002477
Pays : United States

Références

Eur J Prev Cardiol. 2018 Jan;25(2):209-211
pubmed: 29164921
Circulation. 2018 May 1;137(18):e495-e522
pubmed: 29618598
Br J Sports Med. 1998 Jun;32(2):184
pubmed: 9631233
J Geriatr Phys Ther. 2009;32(2):46-9
pubmed: 20039582
Prog Cardiovasc Dis. 2015 Jan-Feb;57(4):315-23
pubmed: 25559060
Heart. 2020 Nov;106(21):1658-1664
pubmed: 32144189
J Am Coll Cardiol. 2015 Feb 3;65(4):389-395
pubmed: 25634839
J Sports Sci. 2021 Jan;39(1):23-30
pubmed: 32755427
Eur J Prev Cardiol. 2014 Nov;21(2 Suppl):26-31
pubmed: 25354951
Int J Cardiol. 2017 Oct 1;244:322-328
pubmed: 28622943
Atherosclerosis. 2006 Nov;189(1):61-9
pubmed: 16620828
Br J Sports Med. 2018 Jun;52(12):769-775
pubmed: 29858464
Circulation. 2000 Oct 31;102(18):2204-9
pubmed: 11056093
Neuroepidemiology. 2007;29(3-4):193-200
pubmed: 18043004
Lancet. 2012 Jul 21;380(9838):192-3
pubmed: 22818933
BMC Cardiovasc Disord. 2018 May 21;18(1):98
pubmed: 29783928
Can J Cardiol. 2016 Sep;32(9):1088-96
pubmed: 27297002
Int J Older People Nurs. 2015 Sep;10(3):170-8
pubmed: 25400233
J Am Coll Cardiol. 2013 Feb 12;61(6):635-42
pubmed: 23391194
J Am Coll Cardiol. 2019 Dec 10;74(23):2948-2950
pubmed: 31806139
Circulation. 2016 Jan 26;133(4):447-54
pubmed: 26811276
J Am Coll Cardiol. 2015 May 19;65(19):2101-3
pubmed: 25975473
N Engl J Med. 2002 Mar 14;346(11):793-801
pubmed: 11893790
Am J Prev Med. 2014 Mar;46(3):265-72
pubmed: 24512865
J Cardiopulm Rehabil Prev. 2012 Sep-Oct;32(5):262-9
pubmed: 22936157
Arch Intern Med. 2012 Jul 23;172(14):1096-102
pubmed: 22710902
Eur J Epidemiol. 2006;21(2):113-22
pubmed: 16518679
Lancet. 2016 Sep 24;388(10051):1337-48
pubmed: 27475273
Am J Prev Med. 2004 Nov;27(4):297-303
pubmed: 15488359
J Am Coll Cardiol. 2010 Nov 9;56(20):1668-76
pubmed: 21050978
Circulation. 2015 Jan 27;131(4):e29-322
pubmed: 25520374
Circulation. 2019 Mar 5;139(10):e56-e528
pubmed: 30700139
Eur J Prev Cardiol. 2018 Jan;25(2):212-219
pubmed: 28990422
Circulation. 2017 Apr 18;135(16):e894-e918
pubmed: 28336790
Prev Chronic Dis. 2004 Oct;1(4):A09
pubmed: 15670441
Prev Med. 1997 Jan-Feb;26(1):131-7
pubmed: 9010908
J Am Coll Cardiol. 2013 May 14;61(19):1964-72
pubmed: 23500222
NCHS Data Brief. 2012 Feb;(86):1-8
pubmed: 22617014
Eur J Cardiovasc Prev Rehabil. 2011 Apr;18(2):158-66
pubmed: 21450662
Circulation. 2013 Nov 12;128(20):2259-79
pubmed: 24126387
Circ Res. 2015 Jul 3;117(2):207-19
pubmed: 26139859
Circulation. 2013 Aug 20;128(8):873-934
pubmed: 23877260
J Cardiopulm Rehabil Prev. 2015 Jan-Feb;35(1):21-8
pubmed: 25313452
BMJ. 2010 Jan 19;340:b5631
pubmed: 20085991
Prog Cardiovasc Dis. 2017 Jun - Jul;60(1):3-10
pubmed: 28089610
BMJ Open. 2013 Oct 25;3(10):e003446
pubmed: 24163203
J Am Geriatr Soc. 2006 Jan;54(1):127-32
pubmed: 16420209
Arch Intern Med. 2009 Apr 13;169(7):694-701
pubmed: 19364999
Br J Gen Pract. 2011 Mar;61(584):e125-33
pubmed: 21375895

Auteurs

Stefano Bonnini (S)

Department of Economics and Management, University of Ferrara, Ferrara, Italy.

Gianni Mazzoni (G)

Center for Exercise Science and Sport, University of Ferrara, Via Gramicia , 35, 44121, Ferrara, Italy.
Public Health Department, AUSL Ferrara, Ferrara, Italy.

Michela Borghesi (M)

Center for Modelling Computing and Statistics, University of Ferrara, Ferrara, Italy.

Giorgio Chiaranda (G)

Public Health Department, AUSL Piacenza, Piacenza, Italy.
General Directorship for Public Health and Integration Policy, Emilia-Romagna Region, Bologna, Italy.

Jonathan Myers (J)

Division of Cardiology, VA Palo Alto, Palo Alto, CA, USA.
Stanford University School of Medicine, Stanford, CA, USA.

Simona Mandini (S)

Center for Exercise Science and Sport, University of Ferrara, Via Gramicia , 35, 44121, Ferrara, Italy. simona.mandini@unife.it.

Andrea Raisi (A)

Center for Exercise Science and Sport, University of Ferrara, Via Gramicia , 35, 44121, Ferrara, Italy.

Sabrina Masotti (S)

Center for Exercise Science and Sport, University of Ferrara, Via Gramicia , 35, 44121, Ferrara, Italy.

Giovanni Grazzi (G)

Center for Exercise Science and Sport, University of Ferrara, Via Gramicia , 35, 44121, Ferrara, Italy.
Public Health Department, AUSL Ferrara, Ferrara, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH